In line with this, recent studies showed that BRAF inhibitors upregulate the Wnt/β-catenin pathway in BRAFV600E-mutant CRC cell lines through FAK activation-mediated phosphorylation of GSK3. Here, BRAF is linked to colorectal carcinoma.